Supernus Pharmaceuticals, Inc. (SUPN)
53.87
-0.40
(-0.74%)
USD |
NASDAQ |
Mar 06, 16:00
53.92
+0.05
(+0.09%)
After-Hours: 20:00
Supernus Pharmaceuticals Cash from Investing (TTM) : 4.106M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Biogen, Inc. | -1.371B |
| BridgeBio Pharma, Inc. | -22.34M |
| Corcept Therapeutics, Inc. | 69.76M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Cytokinetics, Inc. | 16.67M |